Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
29 Oct 2025
Allergic Rhinitis Phenotypes in Children: New Insights
The JECS cohort followed more than 88,000 newborns across Japan, assessing allergic conditions from birth to age four.
27 Oct 2025
GRACE 3.0 Scoring System Transforms Heart Attack Care
A groundbreaking GRACE 3.0 scoring system harnesses AI to enhance heart attack risk prediction and guide personalised treatment worldwide.
27 Oct 2025
The Hidden Risk of Ghost Scans in Ultrasound
A major study exposes high ghost scan rates in trauma ultrasound, prompting urgent calls for improved quality control and clinician training.
25 Oct 2025
Ketamine for Depression Underwhelms in New Study
The KARMA-Dep 2 trial finds ketamine for depression no more effective than placebo in treating hospitalised patients with major depression.
25 Oct 2025
US-RASP Benefits for Large-Volume BPH Patients
US-RASP has emerged as a promising alternative that maintains sexual function while providing comparable outcomes in urinary symptom relief.
25 Oct 2025
Blood Pressure: New Insights on Plasma Proteins
New genetic study links plasma proteins to blood pressure regulation and cardiovascular disease, offering potential targets for heart health therapies.
25 Oct 2025
Glucocorticoid-Mediated Eosinopoiesis in Asthma Explained
This paradoxical effect appears to be context-dependent, influenced by factors such as infection, allergen exposure, and systemic stress.
23 Oct 2025
Stroke After TAVI Remains a Major Challenge
Comprehensive analysis finds limited benefit of Sentinel protection in preventing stroke after TAVI, despite reduced short-term mortality.
22 Oct 2025
Cardiovascular Risk Declines with Heated Tobacco Uptake
Heated tobacco use rises as heart hospitalisations fall in Japan, revealing a compelling new tobacco cardiovascular risk trend.
22 Oct 2025
Migraine App Eases Disability After Emergency Department Visits
Find out how a migraine app enhanced patient outcomes and reduced disability in emergency department migraine care.
←
1
2
3
4
5
6
7
…
48
49
50
→
We’ve noticed you’re accessing
from
North/South America.
View
View